In 1992, Congress passed the Prescription Drug User Fee Act (PDUFA) allowing the U.S. Food and Drug Administration (FDA) to collect fees from drug manufacturers to fund the drug review and approval process. To promote getting novel medicines to patients expeditiously, the act requires the FDA to make its decisions within certain deadlines.
These PDUFA dates provide crucial timing information for biotech investors since FDA approval or lack thereof can create tremendous swings in stock price. Let's explore four companies with PDUFA dates lined up in the first quarter of 2020.
Image source: Getty Images.
Jan. 17 marks the PDUFA date forAimmune Therapeutics (NASDAQ:AIMT) and Palforzia, its immunotherapy for peanut allergy in children and teens. The Palforzia powder is mixed into the patient's food to deliver a small daily dose of peanut protein. Submission of the Biologics License Application (BLA) to the FDA occurred in March, while the FDA convened an advisory committee panel in September to weigh in on the drug's data. The Allergenic Products Advisory Panel voted seven-to-two that the efficacy data supported approval. The panel voted eight-to-one in favor of Palforzia based on its safety profile.
Palforzia addresses a market of more than 1.6 million children and teens in the U.S. with peanut allergies. Combine what appears to be favorable data and a large potential need, and Aimmune's stock could be off to the races. The stock has consistently trended upward since summer.
Epizyme (NASDAQ:EPZM) develops novel treatments for cancers with known genetic causes. Tazemetostat, the company's lead compound, targets the protein EZH2 found in a variety of blood and solid tumors. Epizyme faces a PDUFA date of Jan. 23 for tazemetostat as a treatment for epithelioid sarcoma, a rare subtype of soft tissue sarcomas (STS). First, though, the FDA scheduled an advisory panel to be held on Dec. 18. The outcome of this event will greatly influence its subsequent decision.
From a commercial point of view, seeking a subtype of a subtype with a known genetic marker means the company is seeking very specific patients. This personalized approach can be quite successful as an intervention but challenging to educate oncologists to identify the appropriate patients. Unfortunately, STS, the broader group of cancers this falls into, does not have many good treatment options so physicians likely will embrace new tools for treatment.
After reviewing phase 2 clinical trial data presented at the European Society of Medical Oncology Annual Meeting in October 2018, I'm not excited. Tazemetostat works better in patients who did not receive prior treatment, which seems logical. Those with more advanced disease fared worse. The response rates measuring tumor shrinkage were low, but that is common in STS. The benefit is that this oral treatment seems to work in line with other infused chemotherapy products and thus offers a convenient, potentially less toxic way to combat cancer. I await the views of the panel later this month.
Esperion Therapeutics (NASDAQ:ESPR) holds the distinction of having two PDUFA dates just days apart on Feb. 21 and Feb. 26. First up is bempedoic acid, a once-a-day oral treatment to reduce low-density lipoprotein cholesterol (LDL-C) when added to other lipid-lowering medications. The second PDUFA date will see the FDA weigh in on a combination pill of bempedoic acid and ezetimibe to lower LDL-C in patients with primary hyperlipidemia.
According to Esperion, bempedoic acid works in the liver to prevent cholesterol biosynthesis. Phase 3 clinical trials enrolled more than 4,000 patients with over 2,600 receiving bemedoic acid. This gives the FDA quite a bit of data to mine for both efficacy and safety. Keep in mind that this non-statin alternative could potentially address high cholesterol in 96 million Americans using Esperion's estimate. Therefore, the FDA will not take this decision lightly.
Esperion's current $1.4 billion market cap looks cheap should bempedoic acid get approved. However, because of the size of the potential market, the product launch will require substantial investment. I imagine a pharma suitor will emerge to acquire the company following approval.
March 8 is the PDUFA date for Horizon Therapeutics' (NASDAQ:HZNP) teprotumumab as a treatment for active thyroid eye disease (TED). TED, a serious and progressive eye disease, causes a protrusion on the eye called proptosis. This leads to vision impairment including double vision and vision loss. Teprotumumab, potentially the first-ever FDA approved treatment for TED, successfully demonstrated in phases 2 and 3 clinical trials that it improved proptosis, double vision, and quality of life.
The data looks compelling for the FDA to approve teprotumumab for this autoimmune disease. Horizon also boasts a multidrug product portfolio that generated $936.5 million in net sales so far this year. It expects to achieve between $1.28 billion to $1.3 billion in net sales for all of 2019. An approval for Horizon will add yet another product to its stable. However, for investors, any positive share-price reaction will likely be muted compared to other companies where the approval is the first or only product to get approved.
FDA advisory committee reviews and the approval decisions can propel the stocks of drug developers dramatically. Correct predictions of the outcomes can generate substantial returns for biotech investors. Aimmune and Esperion seem to have the greatest chance for success and commensurate stock appreciation.
See the original post here:
4 Healthcare Stocks With FDA Approvals on the Horizon - The Motley Fool
- How good is fish for your diet? - November 8th, 2009 [November 8th, 2009]
- What foods have both fiber and protein? - November 8th, 2009 [November 8th, 2009]
- Is There Evidence That Acupuncture Works? - November 8th, 2009 [November 8th, 2009]
- What are some good fiber foods? - November 8th, 2009 [November 8th, 2009]
- Can Green Tea fight HIV infection? - November 8th, 2009 [November 8th, 2009]
- Quality of GNC Supplements - November 8th, 2009 [November 8th, 2009]
- The Gene Smart Diet - November 8th, 2009 [November 8th, 2009]
- Tips for eating in a vegetarian lifestyle - November 8th, 2009 [November 8th, 2009]
- Regarding the Starting of a new diet regimen - November 8th, 2009 [November 8th, 2009]
- Thoughts on Dropping Weight - November 8th, 2009 [November 8th, 2009]
- What do doctors think about vitamin E supplements? - November 8th, 2009 [November 8th, 2009]
- What herbs or supplements are commonly used for depression? - November 8th, 2009 [November 8th, 2009]
- Is there a safe way to lose a lot of weight? - November 8th, 2009 [November 8th, 2009]
- Diets that promise you will lose weight - November 8th, 2009 [November 8th, 2009]
- Are Fish Toxins Linked to Diabetes? - November 8th, 2009 [November 8th, 2009]
- Can Plastic Surgery Help Migraines? - November 8th, 2009 [November 8th, 2009]
- Weight Loss Surgery Eradicates Diabetes Symptoms - November 8th, 2009 [November 8th, 2009]
- Found: A Gene That Controls Fat Cells - November 8th, 2009 [November 8th, 2009]
- Sugars and Starches, what's the difference? - November 8th, 2009 [November 8th, 2009]
- Improving your health with a serving of nuts? - November 8th, 2009 [November 8th, 2009]
- Is Your Diet Causing You To Be Depressed? - December 13th, 2009 [December 13th, 2009]
- Placebo Effect: Magnetic Bracelet Therapy - December 13th, 2009 [December 13th, 2009]
- Does serotonin promote sleep? - December 13th, 2009 [December 13th, 2009]
- Decreased energy levels - Overeating, Sleep, Nutrition - February 1st, 2010 [February 1st, 2010]
- When will the body begin to cannibalize muscle tissue? - February 7th, 2010 [February 7th, 2010]
- Foods that are high in antioxidants - February 7th, 2010 [February 7th, 2010]
- Editorial: Reduce health care costs by cutting administrative overhead - April 1st, 2012 [April 1st, 2012]
- Health Care Winners: Centene, Onyxx - April 25th, 2012 [April 25th, 2012]
- Dan Morain: Nurses union puts politics ahead of health - April 25th, 2012 [April 25th, 2012]
- What's next if Obamacare falls? - April 25th, 2012 [April 25th, 2012]
- Global Managed Health Care Services Industry - April 25th, 2012 [April 25th, 2012]
- Immigration Fight Echoes Health-Care Case at High Court - April 25th, 2012 [April 25th, 2012]
- Medical Centers Lead Workplace Wellness Effort - April 25th, 2012 [April 25th, 2012]
- The next health care overhaul? Look to employers - April 25th, 2012 [April 25th, 2012]
- Capital BlueCross Hosts Community Health Care Forums Focused on Managing Costs While Maintaining Quality - April 25th, 2012 [April 25th, 2012]
- County committee to look at area health care - April 25th, 2012 [April 25th, 2012]
- President Obama Calls on Students to Tell Congress: #DontDoubleMyRate - Video - April 25th, 2012 [April 25th, 2012]
- Sen. Coburn: Competition in Health Care to Allocate Resources - Video - April 25th, 2012 [April 25th, 2012]
- Jesse Kelly health care - Video - April 25th, 2012 [April 25th, 2012]
- PHC Vision Statement (short version) - Video - April 30th, 2012 [April 30th, 2012]
- The Bioeconomy Blueprint Panel - Video - April 30th, 2012 [April 30th, 2012]
- Providence Health Care's Vision Statement - Video - April 30th, 2012 [April 30th, 2012]
- Department of Health and Human Services: Minority Health Blogger Townhall - Video - April 30th, 2012 [April 30th, 2012]
- Health care worker accused of stealing identities of brain i - Video - April 30th, 2012 [April 30th, 2012]
- Health Care Reform, Part 1 of 3 | KYVE Insiders Roundtable - Video - April 30th, 2012 [April 30th, 2012]
- Health Care Reform: The ACA and Beyond - Video - April 30th, 2012 [April 30th, 2012]
- Is Broccoli Like Health Insurance? - Video - April 30th, 2012 [April 30th, 2012]
- Did Obama make a mistake on health care? - Video - April 30th, 2012 [April 30th, 2012]
- How Democrats Lie About Health Care - Video - April 30th, 2012 [April 30th, 2012]
- Toobin on Health Care: This was a "judicial hissy-fit" - Video - April 30th, 2012 [April 30th, 2012]
- President Obama says health care law will stand - Video - April 30th, 2012 [April 30th, 2012]
- Obama Defends Health Care Law From 'Judicial Activism' - Video - April 30th, 2012 [April 30th, 2012]
- Obama Healthcare Individual Mandate - Video - April 30th, 2012 [April 30th, 2012]
- President Obama attacks Supreme Court on health care - Video - April 30th, 2012 [April 30th, 2012]
- Raw Audio: High Court Dissects Health Care Act - Video - April 30th, 2012 [April 30th, 2012]
- Health care on trial - Video - April 30th, 2012 [April 30th, 2012]
- Final Day of Health Care Law Arguments Before Supreme Court - Video - April 30th, 2012 [April 30th, 2012]
- Feds to put up $1.9B for Oregon health overhaul - May 4th, 2012 [May 4th, 2012]
- Scuttling health care act will freeze Medicare, White House warns - May 4th, 2012 [May 4th, 2012]
- U.S. Health Care Spending High, But Quality Lags: Report - May 4th, 2012 [May 4th, 2012]
- Yes, the Health-Care Mandate Is About Liberty - May 4th, 2012 [May 4th, 2012]
- Health center gets $1M federal grant - May 4th, 2012 [May 4th, 2012]
- Health-care reform panel considers exchange options for Va. - May 4th, 2012 [May 4th, 2012]
- Hmong health care gap focus of Healthy House dinner - May 4th, 2012 [May 4th, 2012]
- Walsh-led health bill to be unveiled - May 4th, 2012 [May 4th, 2012]
- Ontario health system confusing for ailing seniors, study finds - May 4th, 2012 [May 4th, 2012]
- 'Health Care Deserts' More Common in Black Neighborhoods - May 5th, 2012 [May 5th, 2012]
- With federal money, Oregon kicks health care reform into high gear - May 5th, 2012 [May 5th, 2012]
- Nurse practitioners tackling more 'doctor' tasks - May 5th, 2012 [May 5th, 2012]
- Konza Prairie Health Center Receives $4.5 Million Grant - May 5th, 2012 [May 5th, 2012]
- Alberta wages hurting Sask. health care - May 5th, 2012 [May 5th, 2012]
- House releases plan to cut growth of Massachusetts health spending in half - May 5th, 2012 [May 5th, 2012]
- Mass. House Will Unveil Bill Seeking To Rein In Health Costs - May 5th, 2012 [May 5th, 2012]
- President Obama Welcomes the Kentucky Wildcats - Video - May 5th, 2012 [May 5th, 2012]
- President Obama Speaks on College Affordability - Video - May 5th, 2012 [May 5th, 2012]
- My First Job: Gene Sperling - Video - May 5th, 2012 [May 5th, 2012]
- Health-care costs worry near-retirees - May 7th, 2012 [May 7th, 2012]
- Massachusetts Institutes Health-Care Price Controls. Is America Next? - May 7th, 2012 [May 7th, 2012]
- Massachusetts Moves Toward Health-Care Price Controls. Is America Next? - May 7th, 2012 [May 7th, 2012]
- GOP plan boosts Pentagon, cuts social programs - May 7th, 2012 [May 7th, 2012]